As an original payment method that suits China's national conditions, DIP payment forms combination of disease diagnoses and interventions based on real-world clinical record, which can precisely reflect the clinical resource consumption and make payments based on actual resource consumption. However, neither DRG nor DIP payment methods have adequately considered the differences of value in clinical intervention in payment decisions. Based on globally acceptable value assessment concepts and methods such as multi-criteria decision analysis and analytic hierarchy process, this study conducted analysis on five pilot diseases of acute appendicitis, atrial fibrillation, colorectal cancer, lung cancer and breast cancer, to explore and establish a comprehensive value assessment framework uniquely suitable for DIP grouping methodology. Based on the value assessment results of various DIP groups' interventions under the same diagnosis, a value-based payment adjustment system were proposed for policy makers to reimburse more on high value DIP groups and less on comparatively low value groups. The efficiency of healthcare security fund utilization was improved and the clinical outcomes was promoted under the premise of regional total budget, providing scientific and effective reference for value-based strategic purchase of healthcare security.
Key words
DIP /
comprehensive value assessment /
index system /
value-based payment /
strategic purchase
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 应亚珍.DIP与DRG:相同与差异[J].中国医疗保险,2021(01):39-42.
[2] 许速,谢桦,崔欣,等.基于大数据的病种分值付费的原理与方法[J].中国医疗保险,2020(09):23-28.
[3] PORTER, M E.A strategy for health care reform-toward a value-based system[J].The New England journal of medicine, 2009, 361(2):109-112.
[4] U.S.Department of Health and Human Services.Medicare hospital value-based purchasing plan development issues paper[M/OL].(2007-01-17)[2022-07-31].https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Downloads/Hospital_VBP_Plan_Issues_Paper.pdf.
[5] The Centers for Medicare and Medicaid Services.The hospital value-based purchasing (VBP) program[M/OL].(2023-09-06)[2022-07-31].https://www.cms.gov/medicare/quality/value-based-programs/hospital-purchasing.
[6] The Institute for Clinical and Economic Review (ICER).2020-2023 value assessment framework[M/OL].(2020-10-23)[2022-07-31].http://icer.org/wpcontent/uploads/2020/10/ICER_2020_2023_VAF_102220.pdf.
[7] LAKDAWALLA, D N, et al.Defining elements of value in health care-a health economics approach:an ISPOR special task force report[J].Value in health, 2018, 21(2):131-139.
[8] 国家卫生健康委办公厅.关于规范开展药品临床综合评价工作的通知[A/OL].(2021-07-28)[2022-07-31].http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f4869.shtml.
[9] R.L.KEENEY, et al.Decisions with multiple objectives:preferences and value tradeoffs[J].Cambridge University Press, IEEE transactions on systems, man, and cybernetics,9(7):403.
[10] BELTON, V, T STEWART.Multiple criteria decision analysis:an integrated approach[M].Springer science business media, 2002.
[11] DOLAN, J G, Multi-criteria clinical decision support:a primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare[J].Patient-centered outcomes research, 2010, 3(4):229-248.
[12] MULDER P.Analytic hierarchy process (AHP)[EB/OL].(2017-07-17)[2022-07-31].https://www.toolshero.com/decision-making/analytic-hierarchy-process/.
[13] SAATY R W.The analytic hierarchy process—what it is and how it is used[J].Mathematical modelling, 1987, 9(3):161-176.
